CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs

SHUZHOU, China, Jan. 2, 2020 -- (Healthcare Sales & Marketing Network) -- CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E inves... Biopharmaceuticals, Venture Capital CF PharmTech
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news